Frank J. Williams - Aug 23, 2022 Form 4 Insider Report for Evolent Health, Inc. (EVH)

Role
Director
Signature
/s/ Jonathan Weinberg, Attorney-in-fact
Stock symbol
EVH
Transactions as of
Aug 23, 2022
Transactions value $
-$5,949,500
Form type
4
Date filed
8/25/2022, 04:37 PM
Previous filing
Jun 13, 2022
Next filing
Nov 3, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EVH Class A Common Stock Options Exercise $576K +150K +19.94% $3.84* 902K Aug 23, 2022 Direct F1
transaction EVH Class A Common Stock Sale -$5.36M -150K -16.62% $35.75 752K Aug 23, 2022 Direct F1, F2
transaction EVH Class A Common Stock Options Exercise $698K +50K +6.65% $13.95 802K Aug 24, 2022 Direct F1
transaction EVH Class A Common Stock Sale -$1.86M -50K -6.23% $37.21 752K Aug 24, 2022 Direct F1, F3
holding EVH Class A Common Stock 66.1K Aug 23, 2022 See footnote F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EVH Class A Common Stock Option (right to buy) Options Exercise $0 -150K -25.04% $0.00 449K Aug 23, 2022 Class A Common Stock 150K $3.84 Direct F5
transaction EVH Class A Common Stock Option (right to buy) Options Exercise $0 -50K -22% $0.00 177K Aug 24, 2022 Class A Common Stock 50K $13.95 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.53 to $36.24, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.00 to $37.58, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 Shares held of record by the Frank Williams Irrevocable Trust. Mr. Williams serves as the Trustee of the Frank Williams Irrevocable Trust.
F5 The Class A Common Stock Options exercised vested on December 1, 2014 and December 1, 2015.
F6 The Class A Common Stock Option exercised vested on February 1, 2019.